Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia
- PMID: 19073250
- DOI: 10.1016/j.bbadis.2008.11.010
Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia
Abstract
Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of skeletal development and activating mutations in FGFR3 cause skeletal dysplasias, including hypochondroplasia, achondroplasia and thanatophoric dysplasia. The introduction of the Y367C mutation corresponding to the human Y373C thanatophoric dysplasia type I (TDI) mutation into the mouse genome, resulted in dwarfism with a skeletal phenotype remarkably similar to that of human chondrodysplasia. To investigate the role of the activating Fgfr3 Y367C mutation in auditory function, the middle and inner ear of the heterozygous mutant Fgfr3(Y367C/+) mice were examined. The mutant Fgfr3(Y367C/+) mice exhibit fully penetrant deafness with a significantly elevated auditory brainstem response threshold for all frequencies tested. The inner ear defect is mainly associated with an increased number of pillar cells or modified supporting cells in the organ of Corti. Hearing loss in the Fgfr3(Y367C/+) mouse model demonstrates the crucial role of Fgfr3 in the development of the inner ear and provides novel insight on the biological consequences of FGFR3 mutations in chondrodysplasia.
Similar articles
-
An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.Hum Mol Genet. 2012 Jun 1;21(11):2503-13. doi: 10.1093/hmg/dds065. Epub 2012 Feb 24. Hum Mol Genet. 2012. PMID: 22367969
-
Hearing loss in a mouse model of Muenke syndrome.Hum Mol Genet. 2009 Jan 1;18(1):43-50. doi: 10.1093/hmg/ddn311. Epub 2008 Sep 25. Hum Mol Genet. 2009. PMID: 18818193 Free PMC article.
-
FGFR3 mutation causes abnormal membranous ossification in achondroplasia.Hum Mol Genet. 2014 Jun 1;23(11):2914-25. doi: 10.1093/hmg/ddu004. Epub 2014 Jan 12. Hum Mol Genet. 2014. PMID: 24419316
-
[From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].Ned Tijdschr Geneeskd. 2001 Jun 2;145(22):1056-9. Ned Tijdschr Geneeskd. 2001. PMID: 11414167 Review. Dutch.
-
[Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].Clin Calcium. 2010 Oct;20(10):1490-6. Clin Calcium. 2010. PMID: 20890030 Review. Japanese.
Cited by
-
C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model.PLoS One. 2018 Jul 26;13(7):e0201492. doi: 10.1371/journal.pone.0201492. eCollection 2018. PLoS One. 2018. PMID: 30048539 Free PMC article.
-
Regulation of cell fate and patterning in the developing mammalian cochlea.Curr Opin Otolaryngol Head Neck Surg. 2009 Oct;17(5):381-7. doi: 10.1097/MOO.0b013e3283303347. Curr Opin Otolaryngol Head Neck Surg. 2009. PMID: 19623076 Free PMC article.
-
CD44 is a marker for the outer pillar cells in the early postnatal mouse inner ear.J Assoc Res Otolaryngol. 2010 Sep;11(3):407-18. doi: 10.1007/s10162-010-0211-x. Epub 2010 Apr 13. J Assoc Res Otolaryngol. 2010. PMID: 20386946 Free PMC article.
-
Recent development of AAV-based gene therapies for inner ear disorders.Gene Ther. 2020 Aug;27(7-8):329-337. doi: 10.1038/s41434-020-0155-7. Epub 2020 May 18. Gene Ther. 2020. PMID: 32424232 Free PMC article. Review.
-
A requirement for Fgfr2 in middle ear development.Genesis. 2019 Jan;57(1):e23252. doi: 10.1002/dvg.23252. Epub 2018 Oct 4. Genesis. 2019. PMID: 30253032 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases